| NCT00650923 | National Cancer Institute (NCI) | Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor | 2008-07 | PHASE1 |
| NCT02192541 | National Cancer Institute (NCI) | Neoplasms | 2014-12-02 | PHASE1 |
| NCT04290195 | Amin El Sayed Nawar|Tanta University | Central Retinal Vein Occlusion With Macular Edema | 2019-06-01 | PHASE1|PHASE2 |
| NCT00045266 | Regeneron Pharmaceuticals|National Cancer Institute (NCI) | Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific | 2002-04 | PHASE1 |
| NCT00369655 | National Cancer Institute (NCI) | Metastatic Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer | 2007-01 | PHASE2 |
| NCT01782443 | Dana-Farber Cancer Institute | Carcinoid Tumor | 2013-02-13 | PHASE2 |
| NCT00407485 | National Cancer Institute (NCI) | Adenocarcinoma of the Bladder|Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Squamous Cell Carcinoma of the Bladder|Stage III Bladder Cancer|Stage III Urethral Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer | 2006-11 | PHASE2 |
| NCT00509249 | National Cancer Institute (NCI) | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Secondary Myelodysplastic Syndromes | 2007-09 | PHASE2 |
| NCT00083213 | Regeneron Pharmaceuticals|National Cancer Institute (NCI) | Cancer | 2004-01 | PHASE1 |
| NCT00436501 | National Cancer Institute (NCI) | Fallopian Tube Cancer|Malignant Tumor of Peritoneum|Recurrent Ovarian Epithelial Cancer | 2007-01 | PHASE1|PHASE2 |
| NCT00828139 | National Cancer Institute (NCI) | Extensive Stage Small Cell Lung Cancer|Recurrent Small Cell Lung Cancer | 2009-05 | PHASE2 |
| NCT02590094 | Panhandle Eye Group, LLP | Diabetic Retinopathy | 2015-10 | NA |
| NCT00082823 | Regeneron Pharmaceuticals|National Cancer Institute (NCI) | Cancer | 2004-01 | PHASE1 |
| NCT00369590 | National Cancer Institute (NCI) | Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor | 2006-08 | PHASE2 |
| NCT00450255 | National Cancer Institute (NCI) | Ciliary Body and Choroid Melanoma, Medium+Large Size|Extraocular Extension Melanoma|Iris Melanoma|Metastatic Intraocular Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage III Melanoma|Stage IV Melanoma | 2007-06 | PHASE2 |
| NCT01258855 | National Cancer Institute (NCI) | Metastatic Melanoma|Recurrent Melanoma|Stage III Cutaneous Melanoma AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7 | 2011-01-18 | PHASE2 |
| NCT02173873 | Rafic Hariri University Hospital | Age Related Macular Degeneration|Central Retinal Vein Occlusion | 2014-06 | PHASE1 |
| NCT03712904 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University|Regeneron Pharmaceuticals | Uveal Melanoma | 2019-08-09 | PHASE2 |
| NCT02645734 | Shahid Beheshti University of Medical Sciences | Diabetic Macular Edema | | PHASE2|PHASE3 |
| NCT00462826 | National Cancer Institute (NCI)|Gynecologic Oncology Group | Recurrent Endometrial Carcinoma | 2007-11 | PHASE2 |
| NCT01747551 | Dana-Farber Cancer Institute | Esophageal Cancer|Gastric Cancer | 2013-01 | PHASE2 |
| NCT03423823 | Kapil Kapoor | Wet Macular Degeneration|Wet Age-related Macular Degeneration | 2017-07-07 | PHASE2 |
| NCT01688960 | Regeneron Pharmaceuticals|Sanofi | Solid Tumors | 2012-10 | PHASE1 |
| NCT01941173 | City of Hope Medical Center|National Cancer Institute (NCI) | Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer | 2014-01 | NA |
| NCT00729157 | National Cancer Institute (NCI) | Recurrent Thyroid Gland Carcinoma|Stage III Thyroid Gland Follicular Carcinoma|Stage III Thyroid Gland Papillary Carcinoma|Stage IV Thyroid Gland Follicular Carcinoma|Stage IV Thyroid Gland Papillary Carcinoma | 2008-08 | PHASE2 |
| NCT00036946 | Regeneron Pharmaceuticals|National Cancer Institute (NCI) | Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific | 2001-11 | PHASE1 |
| NCT02159989 | National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm|Fibrolamellar Carcinoma|Metastatic Malignant Solid Neoplasm|Ovarian Carcinoma|Pancreatic Neuroendocrine Tumor|Recurrent Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm|Unresectable Solid Neoplasm | 2014-06-18 | PHASE1 |
| NCT01889680 | NSABP Foundation Inc|Sanofi | Colorectal Cancer|Metastatic Colorectal Cancer | 2014-11 | PHASE2 |
| NCT02298959 | National Cancer Institute (NCI) | Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Colorectal Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Ovarian Carcinoma|Metastatic Renal Cell Carcinoma|Platinum-Resistant Ovarian Carcinoma|Recurrent Melanoma|Recurrent Renal Cell Carcinoma|Refractory Melanoma|Refractory Renal Cell Carcinoma|Sarcoma|Stage IV Colorectal Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8 | 2015-04-08 | PHASE1 |
| NCT00622414 | National Cancer Institute (NCI) | Unspecified Childhood Solid Tumor, Protocol Specific | 2008-04 | PHASE1 |
| NCT00390234 | National Cancer Institute (NCI) | Fallopian Tube Cancer|Female Reproductive Cancer|Ovarian Carcinosarcoma|Ovarian Sarcoma|Recurrent Ovarian Epithelial Cancer|Recurrent Uterine Sarcoma|Stage III Ovarian Epithelial Cancer|Stage III Uterine Sarcoma|Stage IV Ovarian Epithelial Cancer|Stage IV Uterine Sarcoma|Uterine Carcinosarcoma|Uterine Leiomyosarcoma | 2006-09 | PHASE2 |
| NCT02235324 | University of Southern California|National Cancer Institute (NCI) | Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer | 2015-03 | PHASE2 |
| NCT02101918 | National Cancer Institute (NCI) | Multiple Endocrine Neoplasia Type 1|Pancreatic Neuroendocrine Carcinoma | 2014-06-18 | PHASE2 |